{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:37:16Z","timestamp":1778884636930,"version":"3.51.4"},"reference-count":12,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2017,7,6]],"date-time":"2017-07-06T00:00:00Z","timestamp":1499299200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["P50HL083813"],"award-info":[{"award-number":["P50HL083813"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30DK03836"],"award-info":[{"award-number":["P30DK03836"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes Obesity Metabolism"],"published-print":{"date-parts":[[2017,10]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess long\u2010term efficacy and safety of salsalate to improve glycemia in persons with diabetes risk, who are overweight with statin\u2010treated, stable coronary heart disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Glycemic status was assessed in 192 persons without diabetes at baseline in a pre\u2010specified secondary analysis from Targeting INflammation Using SALsalate in CardioVascular Disease (TINSAL\u2010CVD), a multi\u2010center, double\u2010masked, randomized (1:1), placebo\u2010controlled, parallel clinical trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Participants were mostly Caucasian males, age 60\u00b17 years, BMI 31.4\u00b13.0 kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      , fasting glucose 92.8\u00b111.0 mg\/dL, and HbA1c 5.8\u00b10.3%.  Reductions in mean fasting glucose \u20105.70 mg\/dL (95%CI: \u20107.44 to \u20103.97 mg\/dL,\n                      <jats:italic>P<\/jats:italic>\n                      &lt;0.001), HbA1c \u20100.11% (95%CI: \u20100.210 to \u20100.002%,\n                      <jats:italic>P<\/jats:italic>\n                      =0.046) and glycated serum protein \u201081.8 \u03bcg\/mL (95%CI: \u201093.7 to \u201069.9 \u03bcg\/mL,\n                      <jats:italic>P<\/jats:italic>\n                      &lt;0.001) were demonstrated in salsalate compared to placebo\u2010assigned groups over 30 months.  Reductions in fasting glucose and glycated serum protein were greater with salsalate compared to placebo in participants with prediabetes compared to a normoglycemic sub\u2010group (\n                      <jats:italic>P<\/jats:italic>\n                      <jats:sub>interaction<\/jats:sub>\n                      =0.018).  Salsalate lowered total white blood cell counts (mean difference \u20100.7x10\n                      <jats:sup>3<\/jats:sup>\n                      \/\u03bcL, 95%CI: \u20101.0 to \u20100.4 x10\n                      <jats:sup>3<\/jats:sup>\n                      \/\u03bcL,\n                      <jats:italic>P<\/jats:italic>\n                      &lt;0.001) and increased adiponectin (mean difference 1.8 \u03bcg\/mL, 95%CI: 0.9 to 2.6 \u03bcg\/mL,\n                      <jats:italic>P<\/jats:italic>\n                      &lt;0.001) and albuminurea (16.7 \u03bcg\/mg, 95%CI: 6.4 to 27.1 \u03bcg\/mg,\n                      <jats:italic>P<\/jats:italic>\n                      &lt;0.001)  compared to placebo, consistent with previous results for patients with type 2 diabetes taking salsalate for shorter times.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Salsalate improves glycemia in obese persons at increased risk for diabetes, and hence may decrease risk of incident type 2 diabetes.  Salsalate may inform new therapeutic approaches for diabetes prevention, but renal safety may limit clinical utility.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/dom.12940","type":"journal-article","created":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T17:25:25Z","timestamp":1489512325000},"page":"1458-1462","source":"Crossref","is-referenced-by-count":21,"title":["Salsalate improves glycaemia in overweight persons with diabetes risk factors of stable statin\u2010treated cardiovascular disease: A 30\u2010month randomized placebo\u2010controlled trial"],"prefix":"10.1111","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3409-3706","authenticated-orcid":false,"given":"Ninad","family":"Salastekar","sequence":"first","affiliation":[{"name":"Joslin Diabetes Center  Boston Massachusetts"},{"name":"Harvard Medical School  Boston Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanvi","family":"Desai","sequence":"additional","affiliation":[{"name":"Joslin Diabetes Center  Boston Massachusetts"},{"name":"Harvard Medical School  Boston Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Hauser","sequence":"additional","affiliation":[{"name":"Harvard Medical School  Boston Massachusetts"},{"name":"Beth Israel Deaconess Medical Center  Boston Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernst J.","family":"Schaefer","sequence":"additional","affiliation":[{"name":"Tufts University School of Medicine  Boston Massachusetts"},{"name":"Boston Heart Diagnostics  Framingham Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen","family":"Fowler","sequence":"additional","affiliation":[{"name":"Joslin Diabetes Center  Boston Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacey","family":"Joseph","sequence":"additional","affiliation":[{"name":"Joslin Diabetes Center  Boston Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven E.","family":"Shoelson","sequence":"additional","affiliation":[{"name":"Joslin Diabetes Center  Boston Massachusetts"},{"name":"Harvard Medical School  Boston Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison B.","family":"Goldfine","sequence":"additional","affiliation":[{"name":"Joslin Diabetes Center  Boston Massachusetts"},{"name":"Harvard Medical School  Boston Massachusetts"},{"name":"Beth Israel Deaconess Medical Center  Boston Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the TINSAL\u2010CVD study team","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,7,6]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI29069"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra043430"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-2374"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.12.2836"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2016.0605"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-159-1-201307020-00003"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.23.9.1236"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60691-6"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI88884"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.976"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi340"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1798"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdom.12940","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/pdf\/10.1111\/dom.12940","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T04:37:08Z","timestamp":1761885428000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/10.1111\/dom.12940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,6]]},"references-count":12,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["10.1111\/dom.12940"],"URL":"https:\/\/doi.org\/10.1111\/dom.12940","archive":["Portico"],"relation":{},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"value":"1462-8902","type":"print"},{"value":"1463-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,6]]}}}